003220 On Other Exchanges
Korea SE
text size: T | T
Back to Snapshot
Company Description

Contact Info

386 Cheonhodaero



South Korea

Phone: 82 2 2204 7000


Daewon Pharm. Co. Ltd., a pharmaceutical company, manufactures and sells medicines in South Korea and internationally. The company offers vitamins; and medicines for circulatory, respiratory, antibiotic, mental neurological, chemotherapy, and psychoneurosis uses, as well as antipyretic, analgesic, anti-inflammatory, gastrointestinal, antimicrobial, cardiovascular, metabolic, neuromuscular, endocrine, and other drugs. Its principal products include Oramin-F Soft cap., a multivitamin; Pelubi tablet for pain relief; Aquafol inj. for the anti-exogenous infectious bacteria; Megex-I susp., a medicine supplementing subalimentation of cancer patients; Trigel susp./tab. for the therapy of gastritis and duodenal ulcer; and Metran cap. for use in mammalian physiology. Daewon Pharm. Co. Ltd. was founded in 1958 and is headquartered in Seoul, South Korea.


The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

003220 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 003220.
View Industry Companies

Industry Analysis


Industry Average

Valuation 003220 Industry Range
Price/Earnings 19.4x
Price/Sales 1.5x
Price/Book 2.2x
Price/Cash Flow 18.8x
TEV/Sales 1.4x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact DAEWON PHARMACEUTICAL CO LTD, please visit www.daewonpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.